LONDON, 14 November 2017 – Consilium Strategic Communications (“Consilium”), a global leader in healthcare strategic communications, together with Cooley, RBC Capital Markets and Westwicke Partners will host the fifth Annual Healthcare Conference on Tuesday 14 November 2017 in London.
This annual event aims to bring together a breadth of high quality panel speakers from across the international healthcare sector and investment community to provide insight on current areas of interest through discussion, debate and high-quality networking.
With nearly 300 delegates now registered from companies across Europe and the US, as well as representatives of the funding and investment community and business development specialists, this year promises to be our best-attended and most dynamic event yet.
“Interest has been growing steadily in our conference, now a key fixture in the healthcare IR calendar. Our fifth Annual Healthcare Conference, hosted with our partners Cooley, RBC Capital Markets and Westwicke Partners, comes at an exciting and eventful time for the industry. “With an afternoon of panel discussions led by some of the leading voices in our industry from across the US and Europe, on the most pressing topics of the day, this year promises to be our best yet, and we look forward to hosting it.”
Mary-Jane Elliott and Amber Fennell
Managing Partner and Partner & Co-Founder at Consilium Strategic Communications
This year leading figures from across the industry will sharpen their focus around the issues which will shape the sector over the next year and distil the key findings.
Programme for conference:
| 12:00pm – 1:00pm | Lunch |
| 1:00pm – 1.05pm | Welcome and Introductions |
| 1:05pm – 1:15pm | Keynote Speech by Hugo Fry, Sanofi UK |
| 1:15pm – 2:00pm | Accessing Foreign Capital |
| Exploring the goals, benefits and challenges of accessing capital globally and addressing the most pressing questions about the tactics and logistics of an overseas fundraise or listing, with hands-on advice. | |
| Speakers:• Mark Klausner, Westwicke Partners (Panel Chair)• Tim Haines, Abingworth• Giovanni Mariggi, Medicxi• Joe Anderson, Arix Bioscience plc• John Dawson, Oxford Biomedica plc | |
| 2:00pm – 2:45pm | Investing in Diagnosis for Patients and Profitability |
| Diagnosis will play an increasingly central role in healthcare and this panel will look at how patients, and investors, can profit from this. | |
| Speakers:• Chris Gardner, Consilium Strategic Communications (Panel Chair)• Ian Campbell, Innovate UK• Clive Morris, Inivata• Iraj Ali, Syncona• Geoffrey Hamilton-Fairley, Oncimmune• Ian Gilham, Genedrive plc, Horizon Discovery plc | |
| 2:45pm – 3:30pm | The Current M&A Environment |
| Topics will include: what acquirers want in healthcare now, how potential targets should position themselves, and when and why M&A creates long-term value in healthcare. | |
| Speakers:• Tom Stockman, RBC Capital Markets (Panel Chair)• Shaun Chilton, Clinigen plc• Regina Hodits, Wellington Partners• Rolf Hoffman, Stada/Genmab• Linden Thomson, AXA Framlington IM• Dan Thomas, Alliance Pharma | |
| 3:30pm – 4:00pm | BREAK |
| 4:00pm – 4:45pm | The Politics of Healthcare |
| This panel will try to forecast who will benefit, and how the industry should position itself to withstand – and benefit from – the slings and arrows of healthcare fortune. | |
| Speakers:• John Wilkinson, Cooley (Panel Chair)• Joe Wildy, Sanofi UK• Glyn Edwards, Summit Therapeutics• Matt Cooper, NIHR• Karol Sikora, Proton Partners International/University of Buckingham Medical School | |
| 4:45pm – 5:15pm | Fireside chat: Onno van de Stolpe, Galapagos NV, speaking to Clive Cookson, Financial Times |
| 5:15pm – 6:30pm | Networking Drinks |
